What Drug Do They Give You Before an MRI?

The drug most people receive before or during an MRI is a gadolinium-based contrast agent, injected into a vein to make certain tissues show up more clearly on the scan. But gadolinium is far from the only medication that might be involved. Depending on the type of MRI, your medical history, and how you handle enclosed spaces, you could also receive a sedative, a heart-stress drug, an antispasmodic, or even an inhaled gas. Which drug you get depends entirely on what the radiologist needs to see and what your body needs to cooperate.

Gadolinium-Based Contrast Agents

Gadolinium-based contrast agents, often abbreviated GBCAs, are the backbone of contrast-enhanced MRI. They are used in roughly a quarter of all MRI exams worldwide, with brain, spine, blood vessel, and abdominal scans being the most common applications.¹ The first one approved for clinical use, gadopentetate dimeglumine, became available globally in 1988, and since then eight more gadolinium chelates have been developed and approved in various regions.

Gadolinium works because it is a paramagnetic metal, meaning it has strong magnetic properties. When injected into the bloodstream, it interacts with the water molecules in your tissues and causes them to produce a brighter signal on certain MRI sequences.² The result is that areas with lots of blood flow, like tumors, inflamed tissue, or blood vessels, light up compared to their surroundings. Without contrast, many of these areas would look the same as normal tissue.

Pure gadolinium is toxic, so it is always bound inside a cage-like molecule called a chelate. These chelates come in two broad shapes: macrocyclic agents, which wrap the gadolinium inside a rigid ring, and linear agents, which use a more flexible chain structure. Macrocyclic agents hold onto the gadolinium more tightly, which matters for safety reasons discussed below.³ Most imaging centers today prefer macrocyclic agents for routine scans.

The injection itself is typically quick and uneventful. A technologist places a small IV line, usually in your arm or hand, and the contrast flows in over a few seconds. Many people feel a brief cool sensation or a metallic taste. The gadolinium circulates through your body, does its job during the scan, and is then cleared by the kidneys over the following hours.

Sedatives for Anxiety and Claustrophobia

MRI scanners are loud, narrow tubes, and a meaningful fraction of patients struggle to stay inside long enough to complete the exam. In one study of nearly a thousand patients, about 14% needed some form of sedation, whether oral, intravenous, or general anesthesia, just to tolerate the scan.⁴ That number can be even higher for long exams or patients with pre-existing anxiety disorders.

The most common approach for adults is an oral benzodiazepine, typically diazepam (Valium) or lorazepam (Ativan), taken about an hour before the appointment. These drugs reduce anxiety without putting you fully to sleep, which is important because a deeply sedated adult needs monitoring equipment and trained personnel that not every outpatient MRI suite has on hand. Research on cardiac MRI patients found that oral diazepam given before the appointment had a 100% success rate in enabling claustrophobic patients to complete their scans.⁵ If you think you might need sedation, call the imaging center ahead of time. Most will write a prescription or have a protocol in place, but they need advance notice. And you will need someone to drive you home.

How Children Are Sedated for MRI

Young children present a different challenge than anxious adults. It is not just about calming nerves; kids under five or six often cannot hold still for 30 to 60 minutes, and any movement blurs the images. Pediatric MRI sedation is therefore deeper, closer to the level used for minor procedures, and typically administered intravenously with continuous monitoring by an anesthesiologist or a sedation nurse.

Common pediatric protocols combine a drug called dexmedetomidine with midazolam. One retrospective study found that this combination achieved adequate sedation in about 94% of children without needing any extra medication, with most reaching an appropriate sedation level within eight minutes.⁶ Another commonly used drug is propofol, a fast-acting anesthetic familiar to anyone who has had a colonoscopy. When propofol was combined with dexmedetomidine rather than used alone, children experienced significantly fewer adverse events, particularly upper airway obstruction, which dropped from about 26% with propofol alone to around 6% with the combination.⁷

Parents are understandably nervous about sedation, but these protocols have been refined over decades and are considered safe in pediatric imaging centers. The child is monitored throughout the scan, and recovery afterward usually takes 30 to 60 minutes. Some newer strategies, like MRI-compatible video goggles, coaching programs, and “mock scanner” training sessions, aim to reduce the need for sedation in older children who might be able to stay still with the right preparation.

Drugs for Cardiac Stress MRI

If you are getting a cardiac MRI to check for blockages or reduced blood flow to the heart, the radiologist needs to see what happens to your heart muscle under stress. Since you cannot run on a treadmill inside the scanner, a drug is used to simulate the effect of exercise on your coronary arteries.

The most widely used agent in the United States is regadenoson (Lexiscan), a coronary vasodilator approved by the FDA in 2008.⁸ It is given as a single rapid IV push, and within about a minute the coronary arteries dilate. Healthy arteries open wide; arteries with significant plaque cannot dilate as much. When a gadolinium-based contrast agent is injected right after the regadenoson, the difference in blood flow between healthy and compromised heart muscle becomes visible on the images.⁹ The stress drug and the contrast agent work as a team here. After the stress images are captured, aminophylline is often given intravenously to reverse the vasodilation and ease side effects like flushing, headache, or chest tightness.

Adenosine is an older alternative that works on the same receptor but requires a continuous IV infusion rather than a single push, making it logistically trickier. Dobutamine, which stimulates the heart rate directly, is used at some centers, particularly in patients who cannot receive vasodilator agents. The choice between these drugs depends on your medical history, any contraindications like severe asthma, and what the cardiologist specifically needs to evaluate.

Antispasmodic Drugs for Abdominal and Pelvic MRI

Your intestines do not stop moving just because you are lying in a scanner, and that peristaltic motion creates artifacts that blur the images. For abdominal or pelvic MRI exams, particularly those looking at the bowel wall, pancreas, or bladder, a short-acting antispasmodic drug may be injected to temporarily freeze gut movement.

The two most commonly used agents are hyoscine butylbromide (sold as Buscopan in many countries) and glucagon.¹⁰ Hyoscine butylbromide blocks a receptor on the smooth muscle of the gut, causing it to relax. It kicks in quickly after IV injection, with bowel motion reduction beginning within about eight to nine minutes and lasting roughly 45 minutes.¹¹ Glucagon works through a different mechanism but has the same practical effect. In the United States, hyoscine butylbromide is not available, so glucagon is the standard choice. Side effects from either drug are mild and short-lived, usually just dry mouth or brief nausea.

Oral Contrast for Abdominal Scans

Not every MRI drug goes through a vein. For certain abdominal and pelvic studies, you may be asked to drink an oral contrast agent beforehand. These are not the same barium or iodine drinks used for CT scans. MRI oral contrast agents work by altering the signal from fluid inside the bowel, making it easier to distinguish gut loops from other abdominal structures.¹² Some darken the bowel on images while others brighten it, depending on what the radiologist wants to see. The most common ones are dilute iron-based solutions or pineapple juice (yes, actual juice, because its manganese content affects the MRI signal). They are all considered superior to scanning with no oral agent at all.

Gadolinium Safety and Your Kidneys

The biggest safety concern with gadolinium historically has been nephrogenic systemic fibrosis, or NSF, a rare but serious condition involving thickening and hardening of the skin and connective tissues. NSF was linked to gadolinium in patients with severe kidney disease, because damaged kidneys cannot clear the contrast quickly enough, giving the gadolinium time to separate from its chelate cage and deposit in tissues.

The reassuring news is that NSF has become vanishingly rare. After the older, less stable linear agents were identified as the primary culprits, imaging centers switched to macrocyclic or newer linear agents. Consensus guidelines from the American College of Radiology and the National Kidney Foundation now report zero cases of NSF following nearly 5,000 administrations of these safer agents to patients with severely reduced kidney function.¹³ For people with moderate kidney impairment, the risk is considered exceedingly low, and gadolinium can generally be administered safely without special consent.¹⁴ A study of patients with moderate chronic kidney disease who received gadobenate dimeglumine found zero cases of NSF in the follow-up period.¹⁵

If you have known kidney problems, your imaging center will likely check a blood test for kidney function before injecting contrast. For patients with severely impaired kidneys, the decision to use gadolinium is weighed carefully against the diagnostic benefit, and macrocyclic agents are preferred. Dialysis patients may have the contrast cleared with a dialysis session afterward, though the evidence that this prevents NSF is mostly precautionary rather than proven.

Gadolinium Deposits in the Brain

A newer concern, and one that has generated considerable attention since roughly 2014, is that small amounts of gadolinium can be retained in the brain even in people with perfectly healthy kidneys. Studies have found that repeated GBCA administrations lead to gadolinium deposits in specific brain structures, particularly the dentate nucleus and globus pallidus.¹⁶ These deposits show up as changes in signal intensity on subsequent MRI scans and have been confirmed in brain tissue at autopsy.

The deposits are more prominent with linear agents than with macrocyclic ones, consistent with the idea that the less tightly bound gadolinium is more likely to separate and accumulate.¹⁷ Children are not exempt; gadolinium retention has been observed in pediatric patients as well.¹⁸

Here is where it gets frustrating: despite clear evidence that the deposits exist, nobody has been able to show that they cause harm. No neurological symptoms, cognitive changes, or clinical consequences have been convincingly linked to gadolinium brain retention in patients with normal kidney function. That does not mean no harm exists; it means we have not detected it yet. The practical takeaway is that contrast should be used when it adds genuine diagnostic value and avoided when the same information can be obtained without it. Radiologists are already shifting practice in this direction, particularly for patients who need many repeat scans over their lifetime, such as people with multiple sclerosis.

Allergic Reactions to Contrast

True allergic reactions to gadolinium-based contrast agents are uncommon. Most people experience nothing or have mild, transient effects like warmth at the injection site, a brief headache, or a metallic taste. When genuine allergic reactions do occur, they usually fall on the mild end: hives, itching, or nasal congestion. Severe anaphylactic reactions are extremely rare but have been documented, including fatal cases.¹⁹

If you have had a reaction to a GBCA before, tell your imaging team. They can premedicate you with antihistamines and corticosteroids, switch to a different agent, or skip contrast entirely if the clinical question can be answered without it. A prior reaction to iodinated CT contrast does not necessarily predict a reaction to gadolinium, but it does put you in a slightly higher risk category, so it is worth mentioning.

Specialized Liver Contrast

Standard gadolinium agents are “extracellular,” meaning they distribute throughout the bloodstream and the fluid between cells, then wash out. But one agent, gadoxetate disodium (sold as Eovist in the US and Primovist elsewhere), behaves differently. After the usual vascular phase, it is actively taken up by liver cells through specific transporter proteins. This means that 15 to 20 minutes after injection, healthy liver tissue lights up while lesions that lack functional liver cells, such as metastases, stay dark. The contrast between the two is dramatic and has made gadoxetate a valuable tool for detecting and characterizing small liver tumors.²⁰

This property also makes gadoxetate useful for assessing liver function. In patients with advanced liver fibrosis, the uptake and clearance of gadoxetate change in ways that correlate with the expression of the transporter proteins responsible for pulling it into liver cells.²¹ In other words, how well your liver handles this contrast agent can tell the radiologist something about how well your liver is working, not just what it looks like.

Iron Oxide Nanoparticles and Gadolinium Alternatives

Gadolinium is not the only game in town for MRI contrast. Superparamagnetic iron oxide nanoparticles, or SPIOs, represent a distinct class of agents. Rather than brightening tissue on certain sequences the way gadolinium does, iron oxide particles primarily darken tissue by disrupting the local magnetic field. Two SPIO agents have been clinically approved: ferumoxides and ferucarbotran, both specifically for liver MRI.²² Healthy liver tissue, which contains specialized immune cells called Kupffer cells, gobbles up the iron particles and darkens on images, while tumors that lack these cells remain bright.

Iron oxide agents have had a rocky commercial history, with several products withdrawn from the market not because of safety problems but because of limited commercial demand compared to gadolinium. Research interest remains strong, however, particularly for newer applications like targeted molecular imaging and cell tracking in experimental therapies.²³ For a patient with a serious gadolinium allergy or severe kidney disease, iron oxide particles can sometimes offer an alternative, though availability varies by country and institution.

Joint Injections for MR Arthrography

If your MRI is focused on a joint, particularly the shoulder, hip, or wrist, the radiologist may inject a diluted gadolinium solution directly into the joint space before the scan. This procedure, called MR arthrography, distends the joint capsule and coats the internal structures like the labrum and cartilage with contrast, revealing tears or damage that a standard MRI might miss. The gadolinium concentration used for arthrography is much lower than what goes into a vein, carefully diluted so the signal is optimal without overwhelming the image.²⁴ The injection is done under fluoroscopic or ultrasound guidance and typically causes mild joint pressure that resolves within a day.

Inhaled Gases for Lung Imaging

Standard MRI is terrible at imaging lungs because they are mostly air, and air produces almost no MRI signal. An emerging approach uses hyperpolarized gases, particularly xenon-129, to solve this problem. The patient inhales the gas from a bag, and within a single breath-hold, the MRI captures three-dimensional maps of ventilation throughout the lungs. Because xenon-129 dissolves into blood, it can also reveal how efficiently gas is being transferred from the airspaces across the alveolar membrane and into red blood cells.²⁵ Helium-3 was investigated for the same purpose, but xenon-129 has largely taken over because helium-3 is scarce and expensive.²⁶

Hyperpolarized xenon MRI is still considered an emerging clinical tool rather than a routine exam, available mainly at academic medical centers with the specialized equipment needed to polarize the gas. But for conditions like asthma, COPD, cystic fibrosis, and post-COVID lung damage, it provides functional information about regional lung performance that no other imaging technique can match. It is a reminder that “the drug they give you before an MRI” is sometimes not a liquid at all.

Gadolinium During Pregnancy and Breastfeeding

Pregnancy adds a layer of caution to any medical decision, and gadolinium is no exception. Current radiology practice discourages routine use of gadolinium-based contrast during pregnancy because its safety for the developing fetus has not been definitively established. That said, a review in Canadian Family Physician noted that, based on available evidence, gadolinium-based agents appear to be safe in pregnancy, and their use should be considered when the diagnostic study is important for the mother’s health.²⁷

The concern is that gadolinium crosses the placenta, enters the fetal circulation, is excreted into the amniotic fluid by the fetal kidneys, and then can be swallowed and recirculated. This extended exposure theoretically increases the window during which the gadolinium could separate from its chelate. In practice, no confirmed cases of fetal harm from a single clinical dose have been reported, but the data remain limited. The standard advice is to use gadolinium during pregnancy only when the information it provides cannot be obtained any other way and is needed for immediate clinical decision-making.

For breastfeeding mothers, the picture is more reassuring. Extremely small amounts of gadolinium pass into breast milk, and even less is absorbed by the infant’s gut. Most radiology guidelines say that breastfeeding can continue without interruption after a contrast-enhanced MRI, though some mothers choose to pump and discard for 24 hours for peace of mind.

What Happens When Contrast Leaks Out of the Vein

Extravasation, where the injected contrast escapes from the vein into the surrounding tissue, is an uncommon but recognized complication. With gadolinium agents, the injected volumes are small (typically 10 to 20 milliliters) and the fluid is not particularly irritating, so most extravasations cause nothing more than local swelling that resolves on its own. The risk is higher with power-injected CT contrast, which involves much larger volumes at higher pressure, and can in rare cases cause serious tissue damage including compartment syndrome.²⁸ With gadolinium, serious extravasation injuries are very rare. If you feel pain, burning, or swelling at the IV site during injection, tell the technologist immediately so they can stop the infusion and assess.